Risco Risco, Carlos
504  results:
Search for persons X
?
1

Azithromycin in patients with COVID-19: a systematic review..:

Ayerbe, Luis ; Risco, Carlos ; Forgnone, Ivo..
Ayerbe , L , Risco , C , Forgnone , I , Pe´rez-Pinar , M & Ayis , S 2022 , ' Azithromycin in patients with COVID-19: a systematic review and meta-analysis ' , The Journal of antimicrobial chemotherapy , vol. 77 , no. 2 , pp. 303-309 . https://doi.org/10.1093/jac/dkab404.  , 2022
 
?
2

Azithromycin in patients with COVID-19: a systematic review..:

Ayerbe, Luis ; Risco, Carlos ; Forgnone, Ivo..
Ayerbe , L , Risco , C , Forgnone , I , Pe´rez-Pinar , M & Ayis , S 2022 , ' Azithromycin in patients with COVID-19: a systematic review and meta-analysis ' , The Journal of antimicrobial chemotherapy , vol. 77 , no. 2 , pp. 303-309 . https://doi.org/10.1093/jac/dkab404.  , 2022
 
?
 
?
 
?
 
?
12

ESTRATEGIC MANAGEMENT DURING THE TRANSICION PERIOD TO OPTIM..:

Risco Carlos
http://www.revistas.unal.edu.co/index.php/remevez/article/view/13857.  , 2009
 
?
13

Consideraciones diagnósticas y terapéuticas para infeccione..:

Risco, Carlos
http://revistas.unal.edu.co/index.php/remevez/article/view/13859.  , 2009
 
?
14

DIAGNOSIS AND THERAPEUTIC CONSIDERATIONS OF UTERINE INFECTI..:

Risco Carlos
http://www.revistas.unal.edu.co/index.php/remevez/article/view/13859.  , 2009
 
?
15

Estrategic management during the transicion period to optim..:

Risco, Carlos
http://revistas.unal.edu.co/index.php/remevez/article/view/13857.  , 2009
 
1-15